News

PhRMA Spent $10.15 Million on Lobbying in 2012


 

In the first half of 2012, Pharmaceutical Research and Manufacturers of America spent $10.15 million lobbying the federal government, the most of any entity in the health sector, data from the U.S. Senate Office of Public Records show.

The American Medical Association was second in lobbying at $9.05 million and the American Hospital Association was third with $8.12 million. The next two spots were filled by pharmaceutical companies: Merck ($5.89 million) and Pfizer ($5.88 million), according to a search of the senate’s Lobbying Disclosure Act Database, which does not yet contain data for the third quarter.

The largest spender overall in the first half of this year was the U.S. Chamber of Commerce, which reported $42.72 million in lobbying expenses.

Recommended Reading

Survey Finds Support for Health Reform
MDedge Hematology and Oncology
More Hospitals House Palliative Care Teams
MDedge Hematology and Oncology
IOM: Technology, Incentives Can Fix Broken System
MDedge Hematology and Oncology
Payment Reform Needed: The Policy & Practice Podcast
MDedge Hematology and Oncology
ACO-Like Demo Produces 'Modest' Savings
MDedge Hematology and Oncology
Fewer Americans Uninsured in 2011
MDedge Hematology and Oncology
Medicare's Fiscal Fitness: The Policy & Practice Podcast
MDedge Hematology and Oncology
Sequestration Will Hit Pay But Spare Incentives
MDedge Hematology and Oncology
Expanding Medicaid
MDedge Hematology and Oncology
Election Day Draws Closer: The Policy & Practice Podcast
MDedge Hematology and Oncology